ADAPTIMMUNE THERAPEUTICS PLC Available-for-sale Securities, Gross Realized Gain (Loss)
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Available-for-sale Securities, Gross Realized Gain (Loss) of -$646.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2018-03-15
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-12-31 was -$646.00K.
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-09-30 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-06-30 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-03-31 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC available-for-sale securities, gross realized gain (loss) for fiscal 2017 was -$646.00K.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$646.00K derived: sum of 2 quarters · filed 2018-03-15 | -$646.00K derived: sum of 3 quarters · filed 2018-03-15 | -$646.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-03-15 |